High Frequency of Mutations in BTK and PLCG2 in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib Therapy - Université Sorbonne Paris Nord Accéder directement au contenu
Poster De Conférence Année : 2018

Dates et versions

hal-03965956 , version 1 (31-01-2023)

Identifiants

Citer

Carole Fleury, Anne Quinquenel, Luc-Matthieu Fornecker, Loïc Ysebaert, Catherine Thieblemont, et al.. High Frequency of Mutations in BTK and PLCG2 in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib Therapy. Society of Hematologic Oncology, Nov 2018, Houston, United States. 18, pp.S217-S218, 2018, ⟨10.1016/j.clml.2018.07.083⟩. ⟨hal-03965956⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More